Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoke Wan versus glibenclamide in type 2 diabetes
ChiCTR-TRC-08000074Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Xiaoke Wan, glibenclamide and metformin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Peking University People's Hospital. Primary endpoints: Control rate and Failure rate. Started Oct 2007; status: completed.
02
Drugs
Xiaoke Wanglibenclamidemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-08000074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000074.